| scholarly article | Q13442814 |
| P50 | author | Matthias Preusser | Q18001566 |
| Anna S Berghoff | Q64682268 | ||
| Unal Egeli | Q48345246 | ||
| Gülçin Tezcan | Q50884512 | ||
| P2093 | author name string | Berrin Tunca | |
| Gulsah Cecener | |||
| Gerda Ricken | |||
| Ahmet Bekar | |||
| Sahsine Tolunay | |||
| Hasan Kocaeli | |||
| Ferah Budak | |||
| Mevlut Ozgur Taskapılıoglu | |||
| P2860 | cites work | Cancerous stem cells can arise from pediatric brain tumors | Q24569653 |
| MicroRNAs: target recognition and regulatory functions | Q24609584 | ||
| Up-regulation of miR-200 and let-7 by natural agents leads to the reversal of epithelial-to-mesenchymal transition in gemcitabine-resistant pancreatic cancer cells | Q24651034 | ||
| The 2007 WHO classification of tumours of the central nervous system | Q24685772 | ||
| Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method | Q25938999 | ||
| Expression of Smad2 and Smad4 in cervical cancer: absent nuclear Smad4 expression correlates with poor survival | Q61626148 | ||
| IFN- -mediated inhibition of MAPK phosphatase expression results in prolonged MAPK activity in response to M-CSF and inhibition of proliferation | Q61642656 | ||
| Immunohistochemical expression of Bcl2 is an independent predictor of time-to-biochemical failure in patients with clinically localized prostate cancer following radical prostatectomy | Q81005967 | ||
| Brain tumor stem cells | Q81342282 | ||
| Brain tumor stem cells | Q82890374 | ||
| MGMT gene silencing and benefit from temozolomide in glioblastoma | Q27824832 | ||
| Oncomirs - microRNAs with a role in cancer | Q27860773 | ||
| Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets | Q27860792 | ||
| Stem cells, cancer, and cancer stem cells | Q27860878 | ||
| MicroRNA signatures in human cancers | Q27860962 | ||
| Identification of a cancer stem cell in human brain tumors | Q28131688 | ||
| Human cortical glial tumors contain neural stem-like cells expressing astroglial and neuronal markers in vitro | Q28219465 | ||
| Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma | Q28286168 | ||
| Let-7 microRNA inhibits the proliferation of human glioblastoma cells | Q28287254 | ||
| hsa-mir-181a and hsa-mir-181b function as tumor suppressors in human glioma cells | Q28291188 | ||
| Tandem duplication producing a novel oncogenic BRAF fusion gene defines the majority of pilocytic astrocytomas | Q28299301 | ||
| Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial | Q29547224 | ||
| Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma | Q29615607 | ||
| Oncogenic effects of miR-10b in glioblastoma stem cells | Q30414066 | ||
| Interaction of hypoxia-inducible factor-1α and Notch signaling regulates medulloblastoma precursor proliferation and fate. | Q30525687 | ||
| TGFbeta-mediated upregulation of hepatic miR-181b promotes hepatocarcinogenesis by targeting TIMP3. | Q33754007 | ||
| Direct in vivo evidence for tumor propagation by glioblastoma cancer stem cells | Q34035852 | ||
| miR-195, miR-455-3p and miR-10a( *) are implicated in acquired temozolomide resistance in glioblastoma multiforme cells. | Q34113732 | ||
| Serial selection for invasiveness increases expression of miR-143/miR-145 in glioblastoma cell lines | Q34226918 | ||
| A multi-cancer mesenchymal transition gene expression signature is associated with prolonged time to recurrence in glioblastoma | Q34228481 | ||
| The expression and function of microRNAs in chondrogenesis and osteoarthritis. | Q34238501 | ||
| miR-181a/b significantly enhances drug sensitivity in chronic lymphocytic leukemia cells via targeting multiple anti-apoptosis genes | Q34276098 | ||
| Olea europaea leaf extract alters microRNA expression in human glioblastoma cells | Q34283327 | ||
| MicroRNA-145 is downregulated in glial tumors and regulates glioma cell migration by targeting connective tissue growth factor | Q34579942 | ||
| Expression of HOXC9 and E2F2 are up-regulated in CD133(+) cells isolated from human astrocytomas and associate with transformation of human astrocytes | Q34641253 | ||
| Functional profiling of precursor MicroRNAs identifies MicroRNAs essential for glioma proliferation | Q34664043 | ||
| miR-181b is a biomarker of disease progression in chronic lymphocytic leukemia | Q35220412 | ||
| MicroRNA-1826 targets VEGFC, beta-catenin (CTNNB1) and MEK1 (MAP2K1) in human bladder cancer | Q35747341 | ||
| Getting at the root and stem of brain tumors. | Q35810715 | ||
| BMP2 sensitizes glioblastoma stem-like cells to Temozolomide by affecting HIF-1α stability and MGMT expression | Q36347256 | ||
| Outcome and molecular characteristics of adolescent and young adult patients with newly diagnosed primary glioblastoma: a study of the Society of Austrian Neurooncology (SANO) | Q36500411 | ||
| MGMT promoter methylation status and MGMT and CD133 immunohistochemical expression as prognostic markers in glioblastoma patients treated with temozolomide plus radiotherapy. | Q36552798 | ||
| Assessing current therapeutic approaches to decode potential resistance mechanisms in glioblastomas | Q36695514 | ||
| The role of microRNA and other non-coding RNA in the pathogenesis of chronic lymphocytic leukemia | Q36914074 | ||
| Oncogenic miR-181a/b affect the DNA damage response in aggressive breast cancer. | Q37018223 | ||
| MiR-145 functions as a tumor-suppressive RNA by targeting Sox9 and adducin 3 in human glioma cells | Q37187706 | ||
| Glioblastoma and stem cells | Q37229888 | ||
| Brain tumour stem cells: implications for cancer therapy and regenerative medicine. | Q37264940 | ||
| Identification of regions correlating MGMT promoter methylation and gene expression in glioblastomas | Q37344947 | ||
| miR-137 regulates the constitutive androstane receptor and modulates doxorubicin sensitivity in parental and doxorubicin-resistant neuroblastoma cells | Q37581142 | ||
| MicroRNAs: predictors and modifiers of chemo- and radiotherapy in different tumour types | Q37641491 | ||
| Molecular neuro-oncology in clinical practice: a new horizon | Q38125031 | ||
| Glucocorticoid receptor-induced MAPK phosphatase-1 (MPK-1) expression inhibits paclitaxel-associated MAPK activation and contributes to breast cancer cell survival | Q38333315 | ||
| Post-transcriptional regulation of O(6)-methylguanine-DNA methyltransferase MGMT in glioblastomas | Q38338422 | ||
| miR-181b modulates glioma cell sensitivity to temozolomide by targeting MEK1. | Q39156112 | ||
| MicroRNA-153 is tumor suppressive in glioblastoma stem cells. | Q39196866 | ||
| In human glioblastomas transcript elongation by alternative polyadenylation and miRNA targeting is a potent mechanism of MGMT silencing | Q39206459 | ||
| CD133 is essential for glioblastoma stem cell maintenance. | Q39212552 | ||
| miR-181b promotes hepatic stellate cells proliferation by targeting p27 and is elevated in the serum of cirrhosis patients | Q39374420 | ||
| Let-7d functions as novel regulator of epithelial-mesenchymal transition and chemoresistant property in oral cancer | Q39513563 | ||
| ID4 imparts chemoresistance and cancer stemness to glioma cells by derepressing miR-9*-mediated suppression of SOX2. | Q39550625 | ||
| miR-181b modulates multidrug resistance by targeting BCL2 in human cancer cell lines | Q39738386 | ||
| Delivery of Functional Anti-miR-9 by Mesenchymal Stem Cell-derived Exosomes to Glioblastoma Multiforme Cells Conferred Chemosensitivity | Q39776996 | ||
| Participation of an abnormality in the transforming growth factor-beta signaling pathway in resistance of malignant glioma cells to growth inhibition induced by that factor | Q40250973 | ||
| MiR-181b suppresses proliferation of and reduces chemoresistance to temozolomide in U87 glioma stem cells | Q41161526 | ||
| MicroRNA-137 is downregulated in glioblastoma and inhibits the stemness of glioma stem cells by targeting RTVP-1. | Q42123071 | ||
| IDH1 mutations are present in the majority of common adult gliomas but rare in primary glioblastomas | Q42164790 | ||
| miR-153 supports colorectal cancer progression via pleiotropic effects that enhance invasion and chemotherapeutic resistance | Q42921031 | ||
| Intratumoral hypoxic gradient drives stem cells distribution and MGMT expression in glioblastoma. | Q43121364 | ||
| IDH1 mutations as molecular signature and predictive factor of secondary glioblastomas | Q43276389 | ||
| miR-137 restoration sensitizes multidrug-resistant MCF-7/ADM cells to anticancer agents by targeting YB-1. | Q46037039 | ||
| High TGFbeta-Smad activity confers poor prognosis in glioma patients and promotes cell proliferation depending on the methylation of the PDGF-B gene | Q48276455 | ||
| Pathologic diagnosis as the gold standard | Q48799204 | ||
| MEK-ERK signaling dictates DNA-repair gene MGMT expression and temozolomide resistance of stem-like glioblastoma cells via the MDM2-p53 axis | Q48873373 | ||
| The promoter hypermethylation status of GATA6, MGMT, and FHIT in glioblastoma | Q48891682 | ||
| MicroRNA-10b is a prognostic indicator in colorectal cancer and confers resistance to the chemotherapeutic agent 5-fluorouracil in colorectal cancer cells. | Q54324873 | ||
| Glucocorticoid regulation of a novel HPV-E6-p53-miR-145 pathway modulates invasion and therapy resistance of cervical cancer cells. | Q54326806 | ||
| P433 | issue | 5 | |
| P921 | main subject | temozolomide | Q425088 |
| neoplastic stem cells | Q1638475 | ||
| microRNA expression | Q60681249 | ||
| P304 | page(s) | 679-692 | |
| P577 | publication date | 2014-04-02 | |
| P1433 | published in | Cellular and Molecular Neurobiology | Q2333197 |
| P1476 | title | microRNA expression pattern modulates temozolomide response in GBM tumors with cancer stem cells. | |
| P478 | volume | 34 |
| Q50015658 | A comprehensive review of the genetic and biological evidence supports a role for MicroRNA-137 in the etiology of schizophrenia. |
| Q37301832 | Anti-miR delivery strategies to bypass the blood-brain barrier in glioblastoma therapy |
| Q37694434 | Combination of Endothelial-Monocyte-Activating Polypeptide-II with Temozolomide Suppress Malignant Biological Behaviors of Human Glioblastoma Stem Cells via miR-590-3p/MACC1 Inhibiting PI3K/AKT/mTOR Signal Pathway |
| Q58599064 | Correlation of Expression Levels of Micro Ribonucleic Ccid-10b (miR-10b) and Micro Ribonucleic Acid-181b (miR-181b) with Gastric Cancer and Its Diagnostic Significance |
| Q64110961 | Cycling Quiescence in Temozolomide Resistant Glioblastoma Cells Is Partly Explained by microRNA-93 and -193-Mediated Decrease of Cyclin D |
| Q60050769 | Dynamic expression of 11 miRNAs in 83 consecutive primary and corresponding recurrent glioblastoma: correlation to treatment, time to recurrence, overall survival and MGMT methylation status |
| Q36502009 | Emerging targets for glioblastoma stem cell therapy |
| Q38821132 | Evaluation Expression of Microrna-93 and Integrin Β8 in Different Types of Glioma Tumors |
| Q35794896 | Glioblastoma stem cells (GSCs) epigenetic plasticity and interconversion between differentiated non-GSCs and GSCs. |
| Q50055177 | Identification of microRNAs differentially expressed in glioblastoma stem-like cells and their association with patient survival |
| Q37536715 | Long noncoding RNA RP11-838N2.4 enhances the cytotoxic effects of temozolomide by inhibiting the functions of miR-10a in glioblastoma cell lines |
| Q48089299 | MiR-223/PAX6 Axis Regulates Glioblastoma Stem Cell Proliferation and the Chemo Resistance to TMZ via Regulating PI3K/Akt Pathway. |
| Q27002604 | MicroRNA Regulation of Brain Tumour Initiating Cells in Central Nervous System Tumours |
| Q92876704 | MicroRNA Signature in Human Normal and Tumoral Neural Stem Cells |
| Q35805605 | MicroRNA-153 is a prognostic marker and inhibits cell migration and invasion by targeting SNAI1 in human pancreatic ductal adenocarcinoma |
| Q90706208 | MicroRNA-155-3p promotes glioma progression and temozolomide resistance by targeting Six1 |
| Q34991208 | MicroRNA-27a distinguishes glioblastoma multiforme from diffuse and anaplastic astrocytomas and has prognostic value |
| Q50123796 | MicroRNAs as biomarkers for human glioblastoma: progress and potential. |
| Q26747273 | MicroRNAs in glioblastoma multiforme pathogenesis and therapeutics |
| Q34178530 | Olea europaea leaf extract improves the treatment response of GBM stem cells by modulating miRNA expression. |
| Q34478948 | Regulation of expression of O6-methylguanine-DNA methyltransferase and the treatment of glioblastoma (Review). |
| Q38296132 | Toward biosensors for the detection of circulating microRNA as a cancer biomarker: an overview of the challenges and successes. |
Search more.